Key Events This Week
6 Apr: Week opens at Rs.8.50
7 Apr: Golden Cross formation signals potential bullish breakout
8 Apr: Mojo Score upgraded to Sell from Strong Sell
10 Apr: Week closes at Rs.8.94 (+5.18%)
May 29
BSE+NSE Vol: 8.6 k
The next results date for Hindustan Bio Sciences Ltd is scheduled for 30 May 2026....
Read full news article
6 Apr: Week opens at Rs.8.50
7 Apr: Golden Cross formation signals potential bullish breakout
8 Apr: Mojo Score upgraded to Sell from Strong Sell
10 Apr: Week closes at Rs.8.94 (+5.18%)

Hindustan Bio Sciences Ltd, a micro-cap player in the Software Products sector, has seen its investment rating upgraded from Strong Sell to Sell as of 7 April 2026. This change is primarily driven by a shift in technical indicators signalling a mildly bullish trend, despite persistent weaknesses in the company’s financial fundamentals and valuation metrics.
Read full news article
The 50-day moving average has crossed above the 200-day moving average for Hindustan Bio Sciences Ltd, signalling a golden cross on 7 Apr 2026. Yet, the stock declined 4.94% on the same day, while monthly momentum indicators remain bearish. This divergence between the moving averages and price action calls for a detailed examination of the signal's reliability.
Read full news articleAnnual Secretarial Compliance Report for the year ended 31 March 2026
Hindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Hindustan Bio Sciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Intimation of Board Meeting under regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure requirements) regulations 2015
We are hereby submitting the certificate issued by Venture Capital and Corporate Investments Private Limited in compliance with the Regulation 74(5) of SEBI(Depositories and Participants) Regulation 2018 for the Fourth quarter and year ended on 31st March 2026
(30 May 2026)
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available